These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
201 related items for PubMed ID: 12077367
1. Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells. Sadot E, Conacci-Sorrell M, Zhurinsky J, Shnizer D, Lando Z, Zharhary D, Kam Z, Ben-Ze'ev A, Geiger B. J Cell Sci; 2002 Jul 01; 115(Pt 13):2771-80. PubMed ID: 12077367 [Abstract] [Full Text] [Related]
2. Differential interaction of plakoglobin and beta-catenin with the ubiquitin-proteasome system. Sadot E, Simcha I, Iwai K, Ciechanover A, Geiger B, Ben-Ze'ev A. Oncogene; 2000 Apr 13; 19(16):1992-2001. PubMed ID: 10803460 [Abstract] [Full Text] [Related]
3. The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling. Easwaran V, Song V, Polakis P, Byers S. J Biol Chem; 1999 Jun 04; 274(23):16641-5. PubMed ID: 10347231 [Abstract] [Full Text] [Related]
4. Differential nuclear translocation and transactivation potential of beta-catenin and plakoglobin. Simcha I, Shtutman M, Salomon D, Zhurinsky J, Sadot E, Geiger B, Ben-Ze'ev A. J Cell Biol; 1998 Jun 15; 141(6):1433-48. PubMed ID: 9628899 [Abstract] [Full Text] [Related]
5. Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1. Henderson BR, Galea M, Schuechner S, Leung L. J Biol Chem; 2002 Jul 05; 277(27):24258-64. PubMed ID: 11986304 [Abstract] [Full Text] [Related]
6. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells. Tan C, Costello P, Sanghera J, Dominguez D, Baulida J, de Herreros AG, Dedhar S. Oncogene; 2001 Jan 04; 20(1):133-40. PubMed ID: 11244511 [Abstract] [Full Text] [Related]
7. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion. Faux MC, Ross JL, Meeker C, Johns T, Ji H, Simpson RJ, Layton MJ, Burgess AW. J Cell Sci; 2004 Jan 26; 117(Pt 3):427-39. PubMed ID: 14679305 [Abstract] [Full Text] [Related]
8. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells. Maupas-Schwalm F, Robinet C, Augé N, Thiers JC, Garcia V, Cambus JP, Salvayre R, Nègre-Salvayre A. Cancer Res; 2005 Jan 15; 65(2):526-32. PubMed ID: 15695395 [Abstract] [Full Text] [Related]
9. Nuclear beta-catenin displays GSK-3beta- and APC-independent proteasome sensitivity in melanoma cells. Bonvini P, Hwang SG, El-Gamil M, Robbins P, Kim JS, Trepel J, Neckers L. Biochim Biophys Acta; 2000 Feb 28; 1495(3):308-18. PubMed ID: 10699468 [Abstract] [Full Text] [Related]
10. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation. Ha NC, Tonozuka T, Stamos JL, Choi HJ, Weis WI. Mol Cell; 2004 Aug 27; 15(4):511-21. PubMed ID: 15327768 [Abstract] [Full Text] [Related]
11. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer. Caca K, Kolligs FT, Ji X, Hayes M, Qian J, Yahanda A, Rimm DL, Costa J, Fearon ER. Cell Growth Differ; 1999 Jun 27; 10(6):369-76. PubMed ID: 10392898 [Abstract] [Full Text] [Related]
12. beta-catenin is a target for the ubiquitin-proteasome pathway. Aberle H, Bauer A, Stappert J, Kispert A, Kemler R. EMBO J; 1997 Jul 01; 16(13):3797-804. PubMed ID: 9233789 [Abstract] [Full Text] [Related]
13. Regulation of beta-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system. Salomon D, Sacco PA, Roy SG, Simcha I, Johnson KR, Wheelock MJ, Ben-Ze'ev A. J Cell Biol; 1997 Dec 01; 139(5):1325-35. PubMed ID: 9382877 [Abstract] [Full Text] [Related]
14. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription. Bonvini P, An WG, Rosolen A, Nguyen P, Trepel J, Garcia de Herreros A, Dunach M, Neckers LM. Cancer Res; 2001 Feb 15; 61(4):1671-7. PubMed ID: 11245482 [Abstract] [Full Text] [Related]
15. Wnt-independent beta-catenin transactivation in tumor development. Lu Z, Hunter T. Cell Cycle; 2004 May 15; 3(5):571-3. PubMed ID: 15107603 [Abstract] [Full Text] [Related]
16. CK2 phosphorylation of the armadillo repeat region of beta-catenin potentiates Wnt signaling. Song DH, Dominguez I, Mizuno J, Kaut M, Mohr SC, Seldin DC. J Biol Chem; 2003 Jun 27; 278(26):24018-25. PubMed ID: 12700239 [Abstract] [Full Text] [Related]
17. An F-box protein, FWD1, mediates ubiquitin-dependent proteolysis of beta-catenin. Kitagawa M, Hatakeyama S, Shirane M, Matsumoto M, Ishida N, Hattori K, Nakamichi I, Kikuchi A, Nakayama K, Nakayama K. EMBO J; 1999 May 04; 18(9):2401-10. PubMed ID: 10228155 [Abstract] [Full Text] [Related]
18. Targeted degradation of beta-catenin by chimeric F-box fusion proteins. Liu J, Stevens J, Matsunami N, White RL. Biochem Biophys Res Commun; 2004 Jan 23; 313(4):1023-9. PubMed ID: 14706645 [Abstract] [Full Text] [Related]
19. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin. Kolligs FT, Kolligs B, Hajra KM, Hu G, Tani M, Cho KR, Fearon ER. Genes Dev; 2000 Jun 01; 14(11):1319-31. PubMed ID: 10837025 [Abstract] [Full Text] [Related]
20. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Hart M, Concordet JP, Lassot I, Albert I, del los Santos R, Durand H, Perret C, Rubinfeld B, Margottin F, Benarous R, Polakis P. Curr Biol; 1999 Feb 25; 9(4):207-10. PubMed ID: 10074433 [Abstract] [Full Text] [Related] Page: [Next] [New Search]